The Acute Ischemic Stroke market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Acute Ischemic Stroke pipeline products will significantly revolutionize the Acute Ischemic Stroke market dynamics.  

Acute Ischemic Stroke Overview

Acute Ischemic Stroke (AIS) occurs when blood flow through a brain artery is blocked by a clot- amass of thickened blood. Clots are either thrombotic or embolic, depending on where they develop within the body. A thrombotic stroke, more common of the two, occurs when a clot forms within an artery in the brain. An embolic stroke occurs when a clot or small piece of plaque (fatty deposit) breaks off from elsewhere in the body, such as the heart, and travels through the bloodstream only to become stuck in a narrower vessel in the brain.

Some of the key facts of the Acute Ischemic Stroke Market Report: 

• The Acute Ischemic Stroke market size is anticipated to grow with a significant CAGR during the study period (2019-2032) 
• As per the study conducted by Edward C Jauch et. al., nearly 800,000 people suffer from strokes each year in the United States and 82–92% of these strokes are ischemic. Stroke is the fifth leading cause of adult death and disability 
• According to the World Health Organization (WHO), an estimated 15 million individuals worldwide suffer from stroke each year. Of these, 5 million die, and another 5 million are left permanently disabled.
• As per Stroke Association of the United Kingdom, Up to 25% of childhood Ischemic strokes are linked to congenital heart disease 
• Key Acute Ischemic Stroke Companies: Athersys/Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics, Abbvie, and others 
• Key Acute Ischemic Stroke Therapies: MultiStem, BMS986177, LT-3001, Elezanumab, and others 
• The Acute Ischemic Stroke epidemiology based on gender analyzed that men are at higher risk for Acute Ischemic Stroke than women

Get a Free sample for the Acute Ischemic Stroke Market Report 

Key benefits of the Acute Ischemic Stroke Market report:

1. Acute Ischemic Stroke market report covers a descriptive overview and comprehensive insight of the Acute Ischemic Stroke Epidemiology and Acute Ischemic Stroke market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Acute Ischemic Stroke market report provides insights on the current and emerging therapies.
3. Acute Ischemic Stroke market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Acute Ischemic Stroke market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Acute Ischemic Stroke market.

Discover more about therapies set to grab major Acute Ischemic Stroke market share @ Acute Ischemic Stroke market forecast 

Acute Ischemic Stroke Epidemiology Segmentation:

The Acute Ischemic Stroke market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Acute Ischemic Stroke
• Prevalent Cases of Acute Ischemic Stroke by severity
• Gender-specific Prevalence of Acute Ischemic Stroke
• Diagnosed Cases of Episodic and Chronic Acute Ischemic Stroke
•  

Acute Ischemic Stroke Market  

The dynamics of the Acute Ischemic Stroke market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

Download the report to understand which factors are driving Acute Ischemic Stroke epidemiology trends @ Acute Ischemic Stroke Epidemiological Insights 

Acute Ischemic Stroke Therapies and Key Companies

• MultiStem: Athersys/Healios K.K.
• BMS986177: Bristol-Myers Squibb
• LT-3001: Lumosa Therapeutics
• Elezanumab: Abbvie

Scope of the Acute Ischemic Stroke Market Report

• Study Period: 2019–2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Acute Ischemic Stroke Companies:  Athersys/Healios K.K., Bristol-Myers Squibb, Lumosa Therapeutics, Abbvie, and others
• Key Acute Ischemic Stroke Therapies:  MultiStem, BMS986177, LT-3001, Elezanumab, and others
• Acute Ischemic Stroke Therapeutic Assessment:  Acute Ischemic Stroke current marketed and Acute Ischemic Stroke emerging therapies
• Acute Ischemic Stroke Market Dynamics:  Acute Ischemic Stroke market drivers and barriers 
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
• Unmet Needs, KOL’s views, Analyst’s views, Acute Ischemic Stroke  Market Access and Reimbursement 

Table of Contents 

1. Acute Ischemic Stroke Market Report Introduction

2. Executive Summary for Acute Ischemic Stroke

3. SWOT analysis of Acute Ischemic Stroke

4. Acute Ischemic Stroke Patient Share (%) Overview at a Glance

5. Acute Ischemic Stroke Market Overview at a Glance

6. Acute Ischemic Stroke Disease Background and Overview

7. Acute Ischemic Stroke Epidemiology and Patient Population

8. Country-Specific Patient Population of Acute Ischemic Stroke 

9. Acute Ischemic Stroke Current Treatment and Medical Practices

10. Acute Ischemic Stroke Unmet Needs

11. Acute Ischemic Stroke Emerging Therapies

12. Acute Ischemic Stroke Market Outlook

13. Country-Wise Acute Ischemic Stroke Market Analysis (2019–2032)

14. Acute Ischemic Stroke Market Access and Reimbursement of Therapies

15. Acute Ischemic Stroke Market drivers

16. Acute Ischemic Stroke Market barriers

17.  Acute Ischemic Stroke Appendix

18. Acute Ischemic Stroke Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

To know more about Acute Ischemic Stroke treatment, visit @ Acute Ischemic Stroke Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/